Cargando…

Safety and efficacy of long‐term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE Open

BACKGROUND AND AIM: Tofacitinib is an oral small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). We present safety and efficacy data from patients from East Asia (Japan, Korea, and Taiwan) in OCTAVE Open, an open‐label, long‐term extension study. METHODS: Patients in re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuoka, Katsuyoshi, Hisamatsu, Tadakazu, Kim, Hyo Jong, Ye, Byong Duk, Arai, Shoko, Hoshi, Masato, Yuasa, Hirotoshi, Tabira, Junichi, Toyoizumi, Shigeyuki, Shi, Nanzhi, Woo, Joon‐suk, Hibi, Toshifumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles – Gastroenterology (Clinical)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796539/ https://www.ncbi.nlm.nih.gov/pubmed/35734858 http://dx.doi.org/10.1111/jgh.15923

Ejemplares similares

Ulcerative colitis outcomes research in Japan: protocol for an observational prospective cohort study of YOURS (YOu and Ulcerative colitis: Registry and Social network)
por: Yamazaki, Hajime, et al.
Publicado: (2019)

Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies
por: Motoya, Satoshi, et al.
Publicado: (2018)

Corrigendum: Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies
por: Motoya, Satoshi, et al.
Publicado: (2018)

Symptom Improvement of ulceRative colitis after an Induction dose of UStekinumab in Japanese clinical practice (SIRIUS), measured using patient-reported outcomes: a prospective observational study
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2022)

Impact of immunomodulator use on treatment persistence in patients with ulcerative colitis: A claims database analysis
por: Kobayashi, Taku, et al.
Publicado: (2019)

Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan
por: Kobayashi, Taku, et al.
Publicado: (2023)

Tofacitinib in Steroid-Refractory Acute Severe Ulcerative Colitis: A Retrospective Analysis
por: Malakar, Sayan, et al.
Publicado: (2023)

Phase 1 study on the safety and efficacy of E6011, antifractalkine antibody, in patients with Crohn's disease
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2021)

Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study
por: Yamanaka, Hisashi, et al.
Publicado: (2016)

Computer-Aided Prediction of Long-Term Prognosis of Patients with Ulcerative Colitis after Cytoapheresis Therapy
por: Takayama, Tetsuro, et al.
Publicado: (2015)

Macrophages and Dendritic Cells Emerge in the Liver during Intestinal Inflammation and Predispose the Liver to Inflammation
por: Mikami, Yohei, et al.
Publicado: (2014)

Incidence rates for hospitalized infections, herpes zoster, and malignancies in patients with ulcerative colitis in Japan: an administrative health claims database analysis
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2023)

Modified- versus immediate-release tofacitinib in Japanese rheumatoid arthritis patients: a randomized, phase III, non-inferiority study
por: Tanaka, Yoshiya, et al.
Publicado: (2019)

Survival in a Case of Emphysematous Cholecystitis With Sepsis Caused by Clostridium perfringens
por: Hoshi, Yuki, et al.
Publicado: (2023)

The impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis clinical programme
por: Farraye, Francis A., et al.
Publicado: (2021)

Prediction of early clinical response in patients receiving tofacitinib in the OCTAVE Induction 1 and 2 studies
por: Lees, Charlie W., et al.
Publicado: (2021)

Corticosteroid-free efficacy and safety outcomes in patients receiving tofacitinib in the OCTAVE Sustain maintenance study
por: Vavricka, Stephan R., et al.
Publicado: (2022)

Diagnosis and management of intestinal Behçet’s disease
por: Hisamatsu, Tadakazu, et al.
Publicado: (2014)

Diet, microbiota, and inflammatory bowel disease: lessons from Japanese foods
por: Kanai, Takanori, et al.
Publicado: (2014)

Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore
por: Lee, Scott D., et al.
Publicado: (2023)

TGR5 signalling inhibits the production of pro-inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease
por: Yoneno, Kazuaki, et al.
Publicado: (2013)

Post‐marketing analysis for biosimilar CT‐P13 in inflammatory bowel disease compared with external data of originator infliximab in Japan
por: Sagami, Shintaro, et al.
Publicado: (2021)

5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
por: Miyoshi, Jun, et al.
Publicado: (2018)

Efficacy and Safety of Tofacitinib Re-treatment for Ulcerative Colitis After Treatment Interruption: Results from the OCTAVE Clinical Trials
por: Panés, Julian, et al.
Publicado: (2021)

Efficacy and safety of tofacitinib dose de‐escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open
por: Sands, Bruce E., et al.
Publicado: (2019)

Agreement between local and central reading of endoscopic disease activity in ulcerative colitis: results from the tofacitinib OCTAVE trials
por: Feagan, Brian G., et al.
Publicado: (2021)

Phase 1 Dose‐Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Tofacitinib in Japanese Healthy Volunteers
por: Miyoshi, So, et al.
Publicado: (2019)

Development of algorithms for identifying patients with Crohn’s disease in the Japanese health insurance claims database
por: Morikubo, Hiromu, et al.
Publicado: (2021)

Impact of biological agents and tofacitinib for moderate-to-severe ulcerative colitis on health-related quality of life: a protocol for a network meta-analysis
por: Ma, Xueni, et al.
Publicado: (2021)

Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open
por: Biedermann, Luc, et al.
Publicado: (2022)

Intrahepatic Glissonean Approach for Robotic Anatomical Liver Resection of Segment 7 Using the Saline-Linked Monopolar Cautery Scissors (SLiC-Scissors) Method: A Technical Case Report With Videos
por: Fujikawa, Takahisa, et al.
Publicado: (2023)

An Efficient Method of Hepatoduodenal Ligament Taping for Pringle’s Maneuver During Robotic Liver Resection
por: Uemoto, Yusuke, et al.
Publicado: (2023)

Essential Matlab and Octave
por: Rogel-Salazar, Jesus
Publicado: (2014)

Cahiers Octave Mirbeau /
Publicado: (2004)

Cahiers Octave Mirbeau /
Publicado: (1994)

Collagenous Colitis in a Patient With Gastric Cancer Who Underwent Chemotherapy
por: Iwamuro, Masaya, et al.
Publicado: (2023)

Novel Liver Parenchymal Transection Technique Using Saline-linked Monopolar Cautery Scissors (SLiC-Scissors) in Robotic Liver Resection
por: Fujikawa, Takahisa, et al.
Publicado: (2022)

Massive Retroperitoneal Hematoma After Inguinal Hernia Repair Using Prolene® Hernia System: A Case Report
por: Fujikawa, Takahisa, et al.
Publicado: (2023)

GNU Octave by Example: A Fast and Practical Approach to Learning GNU Octave
por: Pajankar, Ashwin
Publicado: (2020)

Diagnosis, Treatment, and Prevention of Ileostomy Complications: An Updated Review
por: Tsujinaka, Shingo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hucj2je8u51ooh3hg3ji9cj2uk